Company intelligence / Profile preview

Recanati

Herzliya, Israel

Ownership: Private
Development stage: Other

Overview

GlenRock Israel is a private investment company founded by Leon Recanati in 2003, following the sale of his family's controlling interest in IDB Holding Corporation. The firm focuses on venture capital investments in startup companies primarily engaged in life sciences, medical devices, and advanced technologies. GlenRock takes an active role in the development and growth of its portfolio companies, providing strategic guidance and leveraging its extensive network within the Israeli and global business communities. Notable portfolio companies include Kamada, Evogene, PolyPid, and Rainbow Medical. The firm serves as a bridge for international investors looking to enter the Israeli technology and healthcare sectors.

Industry: Investors

Partnerships

Shavit CapitalSanara Ventures

Beyond the preview

Go deeper on Recanati.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recanati.

Explore the full profile